XIAP and breast cancer: For example, breast cancer cell lines harboring DNM1L amplifications exhibited hypersensitivity to the ER stress-inducing drug thapsigargin and the XIAP inhibitor embelin as well as resistance to chemically distinct inhibitors of the phosphoinositide 3-kinase (PI3K) pathway (Fig. 1c, d).